VBI craters as investors react to Hep B vaccine dataVBI Vaccines has trumpeted top-line data from a trial pitting its hepatitis B virus (HBV) vaccine candidate against Share XVBI craters as investors react to Hep B vaccine datahttps://pharmaphorum.com/news/vbi-craters-as-investors-react-to-hep-b-vaccine-data/
